Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 May;26(5):911–918. doi: 10.1128/jcm.26.5.911-918.1988

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

G J Gorse 1, R B Belshe 1, N J Munn 1
PMCID: PMC266485  PMID: 3384914

Abstract

Forty seropositive older adults with chronic diseases were vaccinated intranasally with either influenza A/California/10/78 (H1N1) (CR37) or influenza A/Washington/897/80 (H3N2) (CR48) virus. No clinically significant decrements in pulmonary function occurred postvaccination. Eight (62%) recipients of CR37 virus and 16 (59%) recipients of CR48 virus became infected with vaccine virus, as indicated by a fourfold rise in nasal wash immunoglobulin G (IgG) or IgA antibody titer, a fourfold rise in serum antibody titer, isolation of vaccine virus from nasal washings, or all of these. Within 2 years after cold-recombinant virus vaccination, 29 vaccinees received trivalent inactivated influenza virus vaccine parenterally. After inactivated virus vaccination, 23 (79%) vaccinees developed a fourfold rise in nasal wash or serum antibody titer to H1 antigen and 24 (83%) developed a fourfold rise in nasal wash or serum antibody titer to H3 antigen. Significantly more cold-recombinant virus vaccinees developed a fourfold rise in nasal wash IgA antibody to H1 or H3 hemagglutinin compared with inactivated virus vaccinees (17 [43%] versus 9 [17%], P = 0.01). We conclude that these cold-recombinant virus vaccines are safe and immunogenic in seropositive older high-risk adults and more often induced a nasal wash IgA antibody response than the inactivated virus vaccine.

Full text

PDF
911

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker W. H., Mullooly J. P. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980 Dec 5;244(22):2547–2549. [PubMed] [Google Scholar]
  2. Belshe R. B., Van Voris L. P., Bartram J., Crookshanks F. K. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis. 1984 Dec;150(6):834–840. doi: 10.1093/infdis/150.6.834. [DOI] [PubMed] [Google Scholar]
  3. Belshe R. B., Van Voris L. P. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J Infect Dis. 1984 May;149(5):735–740. doi: 10.1093/infdis/149.5.735. [DOI] [PubMed] [Google Scholar]
  4. Belshe R. B., Van Voris L. P., Mufson M. A. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis. 1982 Mar;145(3):311–319. doi: 10.1093/infdis/145.3.311. [DOI] [PubMed] [Google Scholar]
  5. Brandriss M. W., Betts R. F., Mathur U., Douglas R. G., Jr Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines. Am Rev Respir Dis. 1981 Dec;124(6):681–684. doi: 10.1164/arrd.1981.124.6.681. [DOI] [PubMed] [Google Scholar]
  6. Brandriss M. W., Schlesinger J. J., Douglas R. G., Jr Responses of elderly subjects to a new subunit influenza virus vaccine. J Infect Dis. 1982 Feb;145(2):277–277. doi: 10.1093/infdis/145.2.277. [DOI] [PubMed] [Google Scholar]
  7. Clements M. L., Betts R. F., Maassab H. F., Murphy B. R. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers. J Infect Dis. 1984 May;149(5):814–815. doi: 10.1093/infdis/149.5.814. [DOI] [PubMed] [Google Scholar]
  8. Clements M. L., Betts R. F., Murphy B. R. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet. 1984 Mar 31;1(8379):705–708. doi: 10.1016/s0140-6736(84)92222-0. [DOI] [PubMed] [Google Scholar]
  9. Clements M. L., Betts R. F., Tierney E. L., Murphy B. R. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. J Clin Microbiol. 1986 Jan;23(1):73–76. doi: 10.1128/jcm.23.1.73-76.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clements M. L., Betts R. F., Tierney E. L., Murphy B. R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol. 1986 Jul;24(1):157–160. doi: 10.1128/jcm.24.1.157-160.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Clements M. L., Murphy B. R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986 Jan;23(1):66–72. doi: 10.1128/jcm.23.1.66-72.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clements M. L., O'Donnell S., Levine M. M., Chanock R. M., Murphy B. R. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun. 1983 Jun;40(3):1044–1051. doi: 10.1128/iai.40.3.1044-1051.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cox N. J., Maassab H. F., Kendal A. P. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug;97(1):190–194. doi: 10.1016/0042-6822(79)90386-6. [DOI] [PubMed] [Google Scholar]
  14. D'Alessio D. J., Cox P. M., Jr, Dick E. C. Failure of inactivated influenza vaccine to protect an aged population. JAMA. 1969 Oct 20;210(3):485–489. [PubMed] [Google Scholar]
  15. Foy H. M., Allan I., Blumhagen J. M., Cooney M. K., Hall C., Fox J. P. A/USSR and B/Hong Kong vaccine. Field experiences during an A/Brazil and an influenza B epidemic. JAMA. 1981 May 1;245(17):1736–1740. [PubMed] [Google Scholar]
  16. Gorse G. J., Belshe R. B., Munn N. J. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. J Clin Microbiol. 1986 Sep;24(3):336–342. doi: 10.1128/jcm.24.3.336-342.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Johnson P. R., Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986 Jul;154(1):121–127. doi: 10.1093/infdis/154.1.121. [DOI] [PubMed] [Google Scholar]
  18. Little J. W., Douglas R. G., Jr, Hall W. J., Roth F. K. Attenuated influenza produced by experimental intranasal inoculation. J Med Virol. 1979;3(3):177–188. doi: 10.1002/jmv.1890030303. [DOI] [PubMed] [Google Scholar]
  19. MacKenzie J. S. Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly. Br Med J. 1977 Jan 22;1(6055):200–202. doi: 10.1136/bmj.1.6055.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Murphy B. R., Clements M. L., Madore H. P., Steinberg J., O'Donnell S., Betts R., Demico D., Reichman R. C., Dolin R., Maassab H. F. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May;149(5):816–816. doi: 10.1093/infdis/149.5.816. [DOI] [PubMed] [Google Scholar]
  21. Murphy B. R., Nelson D. L., Wright P. F., Tierney E. L., Phelan M. A., Chanock R. M. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun. 1982 Jun;36(3):1102–1108. doi: 10.1128/iai.36.3.1102-1108.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Murphy B. R., Phelan M. A., Nelson D. L., Yarchoan R., Tierney E. L., Alling D. W., Chanock R. M. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981 Mar;13(3):554–560. doi: 10.1128/jcm.13.3.554-560.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ogra P. L., Fishaut M., Gallagher M. R. Viral vaccination via the mucosal routes. Rev Infect Dis. 1980 May-Jun;2(3):352–369. doi: 10.1093/clinids/2.3.352. [DOI] [PubMed] [Google Scholar]
  24. Patriarca P. A., Weber J. A., Parker R. A., Hall W. N., Kendal A. P., Bregman D. J., Schonberger L. B. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985 Feb 22;253(8):1136–1139. [PubMed] [Google Scholar]
  25. Phelan M. A., Mayner R. E., Bucher D. J., Ennis F. A. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand. 1980;8(3):233–242. doi: 10.1016/s0092-1157(80)80039-4. [DOI] [PubMed] [Google Scholar]
  26. Powers R. D., Hayden F. G., Samuelson J., Gwaltney J. M., Jr Immune response of adults to sequential influenza vaccination. J Med Virol. 1984;14(2):169–175. doi: 10.1002/jmv.1890140211. [DOI] [PubMed] [Google Scholar]
  27. Quinnan G. V., Schooley R., Dolin R., Ennis F. A., Gross P., Gwaltney J. M. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis. 1983 Jul-Aug;5(4):748–757. doi: 10.1093/clinids/5.4.748. [DOI] [PubMed] [Google Scholar]
  28. Shore S. L., Potter C. W., Stuart-Harris C. H. Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease. Thorax. 1973 Nov;28(6):721–728. doi: 10.1136/thx.28.6.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith C. B., Kanner R. E., Golden C. A., Klauber M. R., Renzetti A. D., Jr Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis. 1980 Mar;141(3):271–280. doi: 10.1093/infdis/141.3.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sérié C., Barme M., Hannoun C., Thibon M., Beck H., Aquino J. P. Effects of vaccination on an influenza epidemic in a geriatric hospital. Dev Biol Stand. 1977 Jun 1;39:317–321. [PubMed] [Google Scholar]
  31. Wagner D. K., Clements M. L., Reimer C. B., Snyder M., Nelson D. L., Murphy B. R. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol. 1987 Mar;25(3):559–562. doi: 10.1128/jcm.25.3.559-562.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Waldman R. H., Bergmann K. C., Stone J., Howard S., Chiodo V., Jacknowitz A., Waldman E. R., Khakoo R. Age-dependent antibody response in mice and humans following oral influenza immunization. J Clin Immunol. 1987 Jul;7(4):327–332. doi: 10.1007/BF00915555. [DOI] [PubMed] [Google Scholar]
  33. Zahradnik J. M., Kasel J. A., Martin R. R., Six H. R., Cate T. R. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine. J Med Virol. 1983;11(4):277–285. doi: 10.1002/jmv.1890110403. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES